Austrian biotech HeartBeat.bio secures €4.5M for cardioid drug discovery platform – Tech.eu

Austrian biotech HeartBeat.bio secures €4.5M for cardioid drug discovery platform - Tech.eu

HeartBeat.bio secures €4.5 million funding for its cardioid drug discovery platform. It plans to develop first-in-class drugs faster and more efficiently, reducing animal testing.

This content was originally published here.